Holders — by stockHoldings — by fund
ACT CAPITAL MANAGEMENT, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001442273
$153.1M
disclosed book value
62
positions
10.9%
largest position share
Positions, as of 2026-06-30
top 62 of 62 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | KRYSKRYSTAL BIOTECH INC | 45,000 | $16.7M | 10.9% |
| 2 | TGTXTG THERAPEUTICS INC | 251,025 | $13.8M | 9% |
| 3 | ABVXABIVAX SA | 97,000 | $12.9M | 8.4% |
| 4 | CVXCHEVRON CORP | 75,000 | $12.4M | 8.1% |
| 5 | EXMOCEXXON MOBIL CORP | 78,500 | $10.7M | 7% |
| 6 | ARWRARROWHEAD PHARMACEUTICALS INC | 110,100 | $9.0M | 5.9% |
| 7 | VKTXVIKING THERAPEUTICS INC | 209,300 | $8.2M | 5.3% |
| 8 | CELCCELCUITY INC | 62,150 | $6.5M | 4.2% |
| 9 | NKTRNEKTAR THERAPEUTICS | 89,300 | $6.2M | 4.1% |
| 10 | TSLATESLA INC | 10,800 | $4.5M | 3% |
| 11 | CYTKCYTOKINETICS INC | 47,500 | $4.0M | 2.6% |
| 12 | ASTSAST SPACEMOBILE INC | 43,500 | $3.9M | 2.5% |
| 13 | PVLAPALVELLA THERAPEUTICS INC | 22,500 | $3.4M | 2.2% |
| 14 | AMZNAMAZON.COM INC | 12,900 | $3.1M | 2% |
| 15 | NUVBNUVATION BIO INC | 520,000 | $3.0M | 1.9% |
| 16 | XENEXENON PHARMACEUTICALS INC | 48,000 | $2.9M | 1.9% |
| 17 | ETENERGY TRANSFER L P | 133,100 | $2.5M | 1.7% |
| 18 | BEBLOOM ENERGY CORP | 7,500 | $2.3M | 1.5% |
| 19 | FCXFREEPORT-MCMORAN INC | 32,500 | $2.0M | 1.3% |
| 20 | NEBIUS GROUP NV | 6,800 | $1.9M | 1.2% |
| 21 | ALMSALUMIS INC | 51,600 | $1.5M | 0.9% |
| 22 | AMBARELLA INC | 16,000 | $1.4M | 0.9% |
| 23 | CBRSCEREBRAS SYSTEMS INC | 5,600 | $1.2M | 0.8% |
| 24 | DFTXDEFINIUM THERAPEUTICS INC | 25,000 | $1.2M | 0.8% |
| 25 | NOKNOKIA CORP | 82,000 | $1.1M | 0.7% |
| 26 | KURAKURA ONCOLOGY INC | 88,900 | $975,233 | 0.6% |
| 27 | PRAXPRAXIS PRECISION MEDICINES INC | 2,700 | $903,933 | 0.6% |
| 28 | AAOIAPPLIED OPTOELECTRONICS INC | 6,000 | $888,960 | 0.6% |
| 29 | CCJCAMECO CORP | 8,400 | $855,624 | 0.6% |
| 30 | GLUEMONTE ROSA THERAPEUTICS INC | 35,000 | $847,000 | 0.6% |
| 31 | RGNXREGENXBIO INC | 67,500 | $808,650 | 0.5% |
| 32 | MLYSMINERALYS THERAPEUTICS INC | 28,100 | $758,138 | 0.5% |
| 33 | GBTCGRAYSCALE BITCOIN TRUST ETF | 15,400 | $701,008 | 0.5% |
| 34 | VIRVIR BIOTECHNOLOGY INC | 64,300 | $655,217 | 0.4% |
| 35 | PALIPALISADE BIO INC | 307,500 | $642,675 | 0.4% |
| 36 | PLTRPALANTIR TECHNOLOGIES INC | 5,500 | $641,685 | 0.4% |
| 37 | ONON SEMICONDUCTOR CORP | 6,000 | $567,240 | 0.4% |
| 38 | HCCWARRIOR MET COAL INC | 6,000 | $486,960 | 0.3% |
| 39 | CRGYCRESCENT ENERGY COMPANY | 45,000 | $441,900 | 0.3% |
| 40 | MBXMBX BIOSCIENCES INC | 8,000 | $441,600 | 0.3% |
| 41 | KEELKEEL INFRASTRUCTURE CORP | 74,500 | $427,630 | 0.3% |
| 42 | CMPSCOMPASS PATHWAYS PLC | 30,000 | $424,500 | 0.3% |
| 43 | CRVSCORVUS PHARMACEUTICALS INC | 27,000 | $403,380 | 0.3% |
| 44 | ACOGALPHA COGNITION INC | 51,500 | $371,830 | 0.2% |
| 45 | KYTXKYVERNA THERAPEUTICS INC | 40,000 | $356,400 | 0.2% |
| 46 | AXTIAXT INC | 4,900 | $353,192 | 0.2% |
| 47 | INFQINFLEQTION INC | 25,000 | $333,000 | 0.2% |
| 48 | SRRKSCHOLAR ROCK HLDG CORP | 6,000 | $330,000 | 0.2% |
| 49 | PATHUIPATH INC | 30,000 | $326,100 | 0.2% |
| 50 | ANLADLAI NORTYE LTD | 27,000 | $310,500 | 0.2% |
| 51 | ONDSONDAS INC | 37,500 | $309,000 | 0.2% |
| 52 | APCARKO PETE CORP | 15,000 | $282,750 | 0.2% |
| 53 | RYZRYERSON HOLDING CORP | 11,200 | $275,632 | 0.2% |
| 54 | WGSGENEDX HOLDINGS CORP | 4,000 | $274,600 | 0.2% |
| 55 | CEPLCAPSTONE ENERGY PLUS, INC. | 27,500 | $253,000 | 0.2% |
| 56 | MUMICRON TECHNOLOGY INC | 200 | $230,858 | 0.2% |
| 57 | TERRA INNOVATUM GLOBAL NV | 45,000 | $221,400 | 0.1% |
| 58 | VIVOPOWER PLC | 42,500 | $219,725 | 0.1% |
| 59 | SPCXSPACE EXPL TECHNOLOGIES CORP | 800 | $136,688 | 0.1% |
| 60 | LSPDLIGHTSPEED COMMERCE INC | 12,500 | $131,125 | 0.1% |
| 61 | STRATASYS LTD | 10,000 | $85,600 | 0.1% |
| 62 | PDSBPDS BIOTECHNOLOGY CORP | 30,000 | $26,433 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.